Successful Voriconazole Therapy of Disseminated Fusarium Solani in the Brain of a Neutropenic Cancer Patient

Bodey G.P. , Boktour M. , Mays S. . Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002; 47: 659–66.

Nucci M. , Anaissie E. . Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002; 35: 909–920.

Segal B.H. , Bow E.J. , Menichetti F. . Fungal infections in nontransplant patients with hematologic malignancies. Infect Dis Clin North Am. 2002; 16: 935–964, vii.

Rolston K. . Overview of systemic fungal infections. Oncology (Huntingt). 2001; 15(11 suppl 9): 11–14.

Musa M.O. , Al Eisa A. , Halim M. . The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol. 2000; 108: 544–548.

Ponton J. , Ruchel R. , Clemons K.V. . Emerging pathogens. Med Mycol. 2000; 38(suppl 1): 225–236.

Graybill J.R. . Itraconazole: managing mycotic complications in immunocompromised patients. Semin Oncol. 1998; 25(3 suppl 7): 58–63.

Rex J.H. , Walsh T.J. , Anaissie E.J. . Fungal infections in iatrogenically compromised hosts. Adv Intern Med. 1998; 43: 321–371.

Walsh T.J. , Groll A.H. . Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis. 1999; 1: 247–261.

Boutati E.I. , Anaissie E.J. . Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood. 1997; 90: 999–1008.

DeLucca A.J. , Bland J.M. , Jacks T.J. . Fungicidal activity of cecropin A. Antimicrob Agents Chemother. 1997; 41: 481–483.

Mayayo E. , Pujol I. , Guarro J. . Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol. 1999; 48: 363–366.

Uhlinger C. . Leukoencephalomalacia. Vet Clin North Am Equine Pract. 1997; 13: 13–20.

Anaissie E.J. , Kuchar R.T. , Rex J.H. . Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis. 2001; 33: 1871–1878.

Raad I. , Tarrand J. , Hanna H. . Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol. 2002; 23: 532–537.

Velasco E. , Martins C.A. , Nucci M. . Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis. 1995; 14: 697–699.

Clancy C.J. , Nguyen M.H. . The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis. J Antimicrob Chemother. 1998; 41: 27–130.

Clancy C.J. , Nguyen M.H. . In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species. Eur J Clin Microbiol Infect Dis. 1998; 17: 573–575.

Khoury H. , Ball N.J. . Disseminated fusariosis in a patient with acute leukaemia. Br J Haematol. 2003; 120: 1.

Tiribelli M. , Zaja F. , Fili C. . Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. Eur J Haematol. 2002; 68: 314–317.

de Medeiros B.C. , de Medeiros C.R. , Werner B. . Central nervous system infections following bone marrow transplantation: an autopsy report of 27 cases. J Hematother Stem Cell Res. 2000; 9: 535–540.

Bleggi-Torres L.F. , de Medeiros B.C. , Neto J.Z. . Disseminated Fusarium sp. infection affecting the brain of a child after bone marrow transplantation. Bone Marrow Transplant. 1996; 18: 1013–1015.

Steinberg G.K. , Britt R.H. , Enzmann D.R. . Fusarium brain abscess: case report. J Neurosurg. 1983; 58: 598–601.

Abramowsky C.R. , Quinn D. , Bradford W.D. . Systemic infection by Fusarium in a burned child: the emergence of a saprophytic strain. J Pediatr. 1974; 84: 561–564.

Austen B. , McCarthy H. , Wilkins B. . Fatal disseminated Fusarium infection in acute lymphoblastic leukaemia in complete remission. J Clin Pathol. 2001; 54: 488–490.

Pujol I. , Guarro J. , Gene J. . Invitro antifungal susceptibility of clinical and environmental Fusarium spp strains. J Antimicrob Chemother. 1997; 39: 163–167.

Walsh T.J. , Pappas P. , Winston D.J. . Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002; 346: 225–234.

Herbrecht R. , Denning D.W. , Patterson T.F. . Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002; 347: 408–415.

Denning D.W. , Ribaud P. , Milpied N. . Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis. 2002; 34: 563–571.

Johnson L.B. , Kauffman C.A. . Voriconazole: a new triazole antifungal agent. Clin Infect Dis. 2003; 36: 630–637.

Voriconazole. Med Lett Drugs Ther. 2002; 44: 63–65.

Ernst E.J. . Investigational antifungal agents. Pharmacotherapy. 2001; 21(8 pt 2): 165S–174S.

Sheehan D.J. , Hitchcock C.A. , Sibley C.M. . Current and emerging azole antifungal agents. Clin Microbiol Rev. 1999; 12: 40–79.

Machetti M. , Zotti M. , Veroni L. . Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transpl Infect Dis. 2000; 2: 140–144.

Nesky M.A. , McDougal E.C. , Peacock J.E. Jr . Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis. 2000; 31: 673–677.

Sun Q.N. , Fothergill A.W. , McCarthy D.I. . In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of Zygomycetes. Antimicrob Agents Chemother. 2002; 46: 1581–1582.